Interleukin-8 and its receptor CXCR2 in atherosclerosis.
about
Stimulation of interleukin-8 production in human THP-1 macrophages by apolipoprotein(a). Evidence for a critical involvement of elements in its C-terminal domainInflammation and metabolic dysfunction: links to cardiovascular diseasesAsymmetric dimethyarginine as marker and mediator in ischemic strokeRegulation of atherogenesis by chemokines and chemokine receptorsReduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells.Expanded network of inflammatory markers of atherogenesis: where are we now?Gene targeting of chemokines and their receptors.Activation of myocardial phosphoinositide-3-kinase p110α ameliorates cardiac dysfunction and improves survival in polymicrobial sepsis.Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids.Hypoxia-inducible factors as essential regulators of inflammation.Role of monocytes in atherogenesis.Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis.Inherited human group IVA cytosolic phospholipase A2 deficiency abolishes platelet, endothelial, and leucocyte eicosanoid generation.The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques15-deoxy-Δ12,14 -prostaglandin J 2 Down-Regulates Activin-Induced Activin Receptor, Smad, and Cytokines Expression via Suppression of NF- κ B and MAPK Signaling in HepG2 CellsEffect of the +781C/T polymorphism in the interleukin-8 gene on atherosclerotic cerebral infarction, and its interaction with smoking and drinking.Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis.Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis.Chemokines in the vascular inflammatory response of atherosclerosis.Roles of the chemokine system in development of obesity, insulin resistance, and cardiovascular disease.CXCR2 in acute lung injury.How do we prevent the vulnerable atherosclerotic plaque from rupturing? Insights from in vivo assessments of plaque, vascular remodeling, and local endothelial shear stress.Macrophage-mediated response to hypoxia in disease.IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation.Different cytokine response of primary colonic epithelial cells to commensal bacteria.Effects of 15-deoxy-∆¹²,¹⁴-prostaglandin J₂ on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide.Low level of inflammatory marker in hyperhomocysteinemic patients on statin therapy.Biochemical markers for cardiovascular risk following treatment in endogenous Cushing's syndrome.IL-8 Gene Variants and Expression in Childhood Asthma.Cathepsin G deficiency decreases complexity of atherosclerotic lesions in apolipoprotein E-deficient mice.
P2860
Q24291770-FA0A2BE7-4A1E-46ED-BB68-D6051E1CAE82Q26851186-69361944-84A3-407D-91EF-ED13F1CEBAA8Q26864318-D5339CA7-4D88-4389-9A05-528DD1C2F284Q27003124-19B75135-5149-439C-BE3F-D17980FF3444Q33581032-29587DD3-2D2C-4587-9CBA-2CEA62E63B60Q33738532-BF37C827-59D6-46A0-BBEA-E80F96E3B12FQ34129761-8DC9AC9F-F233-4983-BFE0-360B357129F9Q34427286-9D5602C7-C17A-46B2-A2E8-EFDB0795D07DQ35036420-9AEEBFCB-3DE0-4B36-A54F-C205341F7311Q35130618-FB8A850A-D4DE-41D6-813B-61239BA5DB10Q35541858-EB81782F-E094-46FB-86E8-259B721D213EQ35992029-9970D2CA-1A47-44FE-BBA7-2875B20C6C16Q36171277-6AD8924D-CA45-4BAE-9A9F-6CA32D91925BQ36940248-5EF873C8-6948-4ABB-A373-1FF19C30E225Q37239632-E238A9B2-6C37-4D79-8620-B3FFC9AB134FQ37288420-11C0FF36-C59A-4393-B675-15375E147335Q37344018-89F6A50A-BE4D-4821-B235-E635EDBA28AFQ37522878-6454B575-BCD5-4143-B1F9-584E251C8C90Q37652971-6351A405-0227-46FE-8F0D-1C82F993A091Q37704741-3CC13F8C-3203-4F5A-96F0-FCC93D0AC0D3Q38020471-61F3C18F-4C2A-4F51-91AF-0BEC2FC2E325Q38261883-125BCC45-F6E0-428F-8413-D92250DAAAEDQ38989145-3296BA8F-F1D1-4CFC-971B-4B9FD52C5091Q39496836-BC08A332-0C01-43FF-8289-5194ADAD9DB6Q41899318-F28067FD-A540-434F-A4F2-9E38B4DADAC1Q43154520-794F5B9D-58D2-4CFD-8371-429E0489E98BQ44914830-9115C1D9-0ACA-4AB3-9400-460738BDB1B1Q46535201-8B21DE40-E857-4C48-A9DB-436D11B60E7EQ47673902-5AB3F1F3-8319-490E-B9A9-ED50690E9713Q47806404-65FCD84C-8FD0-4EAE-A6D9-58288FA63726
P2860
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@ast
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@en
type
label
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@ast
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@en
prefLabel
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@ast
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@en
P2093
P356
P1433
P1476
Interleukin-8 and its receptor CXCR2 in atherosclerosis.
@en
P2093
Boisvert WA
Curtiss LK
Terkeltaub RA
P2888
P304
P356
10.1385/IR:21:2-3:129
P577
2000-01-01T00:00:00Z
P6179
1028604748